Results 271 to 280 of about 8,252,790 (324)
Some of the next articles are maybe not open access.
JAMA Oncology, 2018
Importance Accelerated approval (AA) is a US Food and Drug Administration (FDA) expedited program intended to speed the approval of drugs and biologics that may demonstrate a meaningful advantage over available therapies for diseases that are serious or ...
J. Beaver +11 more
semanticscholar +1 more source
Importance Accelerated approval (AA) is a US Food and Drug Administration (FDA) expedited program intended to speed the approval of drugs and biologics that may demonstrate a meaningful advantage over available therapies for diseases that are serious or ...
J. Beaver +11 more
semanticscholar +1 more source
Tardive Dyskinesia Drug Approved
JAMA, 2017The first drug for adults with tardive dyskinesia (TD) has received FDA approval. Tardive dyskinesia is a neurological disorder that causes repetitive, involuntary movements such as abnormal tongue and lip movements, cheek bulging, foot tapping, shoulder shrugging, and rocking and swaying movements.
openaire +2 more sources
Alzheimer Drug Lecanemab Gains Traditional FDA Approval.
Journal of the American Medical Association (JAMA), 2023Emily Harris
semanticscholar +1 more source
The Nurse Practitioner, 2014
This article highlights important prescribing information for new drugs approved by the FDA over the last year. These include albiglutide, apremilast, dapagliflozin, insulin human inhalation powder, riociguat, timothy grass pollen allergen extract, umeclidinium and vilanterol inhalation powder, and vorapaxar.
openaire +2 more sources
This article highlights important prescribing information for new drugs approved by the FDA over the last year. These include albiglutide, apremilast, dapagliflozin, insulin human inhalation powder, riociguat, timothy grass pollen allergen extract, umeclidinium and vilanterol inhalation powder, and vorapaxar.
openaire +2 more sources
Nature Reviews Drug Discovery, 2015
The FDA approved 41 new therapeutics in 2014, but the bumper year fell short of the commercial power of the drugs approved in 2013.
openaire +2 more sources
The FDA approved 41 new therapeutics in 2014, but the bumper year fell short of the commercial power of the drugs approved in 2013.
openaire +2 more sources
Accelerating drug development and approval
Drug News & Perspectives, 2010Regulatory agencies are the gateway between the pharma/biotech industry and patients and can serve as stimulators of new drug development. This article highlights several means of doing so implemented thus far, many with already impressive histories, such as orphan drug legislation, and others of a more experimental nature, such as the FDA's priority ...
openaire +2 more sources
First de novo deuterated drug poised for approval
Nature reviews. Drug discovery, 2022Asher Mullard
semanticscholar +1 more source
Non-Approved Use of Food and Drug Administration Approved Drugs
American Journal of Ophthalmology, 1979J S, Mindel, J I, Goldstein
openaire +2 more sources

